HIGHLIGHTS
- who: Maurizio Valeriani et al. from the Department of Medicine and Surgery and Translational Medicine, Sapienza University of Rome, Radiotherapy Oncology, St Andrea Hospital, Rome, Italy have published the article: Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results, in the Journal: (JOURNAL)
- what: The aim of this study was to evaluate efficacy, toxicity, and prognostic factors in a series of intermediate-risk prostate cancer patients treated with 15 fractions of HyRT + HT with or without image-guided radiotherapy (IGRT). The authors investigate, in this study, the impact of IGRT, showing no statistically . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.